WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- An algorithm can identify individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) with about 88 percent accuracy using electronic medical record (EMR) data, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held from Nov.